Use access key #2 to skip to page content.
$4.84 0.83 (20.70%)
10/13/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

8

Avatar canadianbikeguy (< 20) Submitted: 6/01/06 1:50 AM : Outperform Start Price: $10.91 EXEL Score: -26.24

biotech will have it's day again in the next two years.......and this little company has a strong pipeline giving it a high probability of some kind of success in the short, medium and long terms.

Report this Post Replies: 0 | Reply

Featured Broker Partners